FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmacology and medicine and deals with application of 2,9-disubstituted imidazo[1,2-a]benzimidazoles of formula 
as medications, exhibiting properties of antagonist of serotonin 5-HT2A-receptors, which can be used for creation of efficient medications, capable of treating a number of pathological states of organism.
EFFECT: creation of efficient medications, capable of treating a number of pathological states of organism.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION OF ANTIMIGRAINE ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2019 |
|
RU2696866C1 |
| AGENT SHOWING SEROTONIN 5-HT-RECEPTOR ANTAGONIST PROPERTIES | 2010 |
|
RU2438669C1 |
| KAPPA-OPIOID AGONIST | 2009 |
|
RU2413512C1 |
| SUBSTANCES FOR PANCREATITIS PREVENTION AND TREATMENT | 2006 |
|
RU2423692C2 |
| 9-(2-DIETHYLAMINOETHYL)-2-PHENYLIMIDAZO[1,2-a]BENZIMIDAZOLE HYDROBROMIDE ELICITING PROPERTY OF SEROTONIN 5-HT-RECEPTOR ANTAGONIST | 2005 |
|
RU2285006C1 |
| COMPOUNDS, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION, SELECTIVE ANTAGONISTS OF 5-HT -RECEPTOR | 2001 |
|
RU2280034C2 |
| LIGAND WITH WIDE RANGE OF SIMULTANEOUS RECEPTOR ACTIVITY, PHARMACEUTICAL COMPOSITION, METHOD OF PREPARING SAID COMPOSITION AND MEDICINAL AGENT | 2008 |
|
RU2374245C1 |
| ANTISPASMODIC MEDICATION | 2014 |
|
RU2568841C1 |
| COMPOUND OF 2,3,4-TRIMETHOXY-N-(2,2,6,6-TETRAMETHYLPIPERIDIN-4-YLIDENE)BENZOHYDRAZIDE HYDROCHLORIDE WITH ANTISEROTONIN CEREBROVASCULAR AND ANTIMIGRAINE ACTIVITY | 2022 |
|
RU2803750C1 |
| WAY TO TREAT LIVER CIRRHOSIS | 2022 |
|
RU2800017C1 |
